Ross Hamblin
@hamblinendo.bsky.social
Endocrinologist. Clinical researcher focussing on the optimal management of patients with pituitary tumours. Bristol/Birmingham UK.
Reposted by Ross Hamblin
New content online: Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
Nature Reviews Endocrinology, Published online: 24 June 2025; doi:10.1038/s41574-025-01134-8This international Consensus Statement provides guidelines on the management of pituitary incidentalomas.
www.nature.com
June 24, 2025 at 8:03 AM
New content online: Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
Reposted by Ross Hamblin
Paper is out Open access doi.org/10.1093/ejen...
UK cohort of conservatively managed non-functioning pituitary macroadenomas Data guiding clinical practice. Many thanks to all collaborators! @endocrinesociety.bsky.social
UK cohort of conservatively managed non-functioning pituitary macroadenomas Data guiding clinical practice. Many thanks to all collaborators! @endocrinesociety.bsky.social
May 8, 2025 at 7:20 PM
Paper is out Open access doi.org/10.1093/ejen...
UK cohort of conservatively managed non-functioning pituitary macroadenomas Data guiding clinical practice. Many thanks to all collaborators! @endocrinesociety.bsky.social
UK cohort of conservatively managed non-functioning pituitary macroadenomas Data guiding clinical practice. Many thanks to all collaborators! @endocrinesociety.bsky.social
Reposted by Ross Hamblin
Our paper is out! Responses of patients with pituitary adenoma treated or not with dopamine agonist in two instruments/questionnaires applied in clinical practice for assessing impulse control disorders. link.springer.com/article/10.1...
Impulse control disorders in patients with pituitary adenoma managed with or without dopamine agonists: a cross-sectional study from a UK centre - Pituitary
Purpose Studies from various countries raise concerns on the association between dopamine agonist (DA) treatment and impulse control disorders (ICDs) in patients with pituitary adenomas. We investigat...
link.springer.com
April 21, 2025 at 5:42 PM
Our paper is out! Responses of patients with pituitary adenoma treated or not with dopamine agonist in two instruments/questionnaires applied in clinical practice for assessing impulse control disorders. link.springer.com/article/10.1...